In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...

To make further progress in understanding the unique cardiac disease characteristics of patients with HFpEF and a normal NT-proBNP level and to better tailor treatment, future studies should ...

Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...

In people with no history of CV disease, N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can predict a higher risk of developing CV disease across various blood pressure and pulse pressure ...

Please provide your email address to receive an email when new articles are posted on . Among patients with HF with reduced ejection fraction, elevated N-terminal pro-B-type natriuretic peptide level ...

Elevated levels of N-terminal pro–B-type natriuretic peptide (NT-proBNP), a key biomarker for diagnosing heart failure, show a nearly fourfold increased risk for atrial fibrillation (AF) in at-risk ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center Mortality goes up in tandem with admission natriuretic peptide levels in patients with severe ...

Please provide your email address to receive an email when new articles are posted on . NT-proBNP may predict CV death, incident HF and fatal or nonfatal CV events after acute MI. The association was ...

The device gained approval in the US in 2019 and received CE marking for use in the EU in 2014.